28
Participants
Start Date
April 30, 2009
Primary Completion Date
July 31, 2012
Study Completion Date
July 31, 2012
Pentoxifylline
400 mg, 3 times daily by mouth from time of enrollment until 72 hours from enrollment. Subjects received up to a maximum of 9 doses.
Placebo
400 mg, 3 times daily by mouth from time of enrollment until 72 hours from enrollment. Subjects received up to a maximum of 9 doses.
Mayo Clinic, Rochester
Lead Sponsor
Mayo Clinic
OTHER